Oxford Global: 3rd Annual Cell & Therapy Congress

About Conference

 

Oxford Global is proud to announce that early bird registration is open for the 3rd Annual Cell & Therapy Congress, 6-7 November 2017 in London. Across the two days 250+ senior level attendees will join us in London to hear 20+ presentations and case studies giving you the chance to explore the key areas shaping this exclusive field of genomic medicine.

 

There are 2 interactive streams:

 

Cell & Gene Therapy: Development & Clinical Trials

Cell Therapy Bioprocessing & Manufacturing

 

Experts and Speakers

 

A truly unmissable congress; hear from internationally renowned senior experts in the cell & gene therapy field, including:

 

Transfering therapies into commercial pathways: Sven Kili, Vice President and Head of Gene Therapy Development, GlaxoSmithKline

 

Regulatory updates within the cell and gene therapy field: Katherine Tsokas, Regulatory Head of Regenerative Medicine & Advanced Therapy, Janssen Research & Development

 

Manufacturing of clinical grade CAR-T NKR-2 THINK in hematological and solid tumors: Sylvain Arnould, the Director of Process Development & Production, Celyad

 

Cell line development bioprocessing within the cell and gene field: Verena Vanessa Fischer, Lab Head in Early Stage Bioprocess Development, Boehringer Ingelheim

 

2017 Cell & Gene Therapy Speakers Include:

 

 

Contact us

 

Angela Fernandez Saez

Tel: +447956 710599

Email: a.fernandez@oxfordglobal.co.uk